Balance Sheet
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding (Weighted Average) (2019 - 2025)

Cellebrite DI has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $241.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $241.6 million for Q4 2025, up 15.35% from a year ago — trailing twelve months through Dec 2025 was $241.6 million (up 15.35% YoY), and the annual figure for FY2025 was $241.6 million, up 15.35%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $241.6 million at Cellebrite DI, up from $209.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CLBT hit a ceiling of $241.6 million in Q4 2025 and a floor of $144.0 million in Q4 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $190.2 million (2023), compared with a mean of $193.6 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 26.87% in 2022 and later grew 4.08% in 2023.
  • Cellebrite DI's Shares Outstanding (Weighted Average) stood at $144.0 million in 2021, then grew by 26.87% to $182.7 million in 2022, then rose by 4.08% to $190.2 million in 2023, then grew by 10.16% to $209.5 million in 2024, then grew by 15.35% to $241.6 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $241.6 million (Q4 2025), $209.5 million (Q4 2024), and $190.2 million (Q4 2023) per Business Quant data.